The Food and Drug Administration (FDA) on Wednesday authorized booster shots for Moderna and Johnson & Johnson vaccines for certain eligible populations, adding that people can take a different vaccine brand than the ones they’d taken originally. The booster campaign for those aged 65 and over and those at high risk aims to increase protection against COVID-19…
FDA Authorizes Moderna, J&J Booster Shots, ‘Mix and Match’ Approach
Facts Matter (Oct. 20): As FDA Approves Booster Shot, J&J Faces 34,600 Lawsuits for Alleged Asbestos Powder
In New York City, the Public Design Commission unanimously voted to remove a nearly 200-year-old statue of Thomas Jefferson from city hall—meaning that our nation’s first secretary of state, drafter of the Declaration of Independence, and the nation’s third president has officially been canceled. Meanwhile, while everyone has been focusing on the FDA’s approval of…
J&J Keeps Vaccine Sales Outlook Unchanged After Third-Quarter Miss
October 19, 2021
admin
Business & EconomyCCP VirusCompanieseconomyJohnson JohnsonMarketsOutlookquartersalesUSUS NewsVaccineVaccines & Safety
0 Comment
Johnson & Johnson on Tuesday reported lower-than- expected quarterly revenue after sales of its COVID-19 vaccine missed Wall Street estimates following a string of production setbacks. The New Brunswick, New Jersey-based company maintained its 2021 sales goal of $2.5 billion from the vaccine, and said it recorded $766 million in sales of the shot in…
Idea of Mixing and Matching COVID-19 Vaccines Gains Momentum
The idea of mixing and matching different COVID-19 vaccines is gaining momentum, with a special focus on letting Johnson & Johnson (J&J) vaccine recipients get a dose produced by a different company. The J&J produces inferior results compared to the vaccines that were created using messenger RNA technology. The main reason to allow heterologous vaccination schedules…
Idea of Mixing, Matching COVID-19 Vaccines Gains Momentum
The idea of mixing and matching different COVID-19 vaccines is gaining momentum, with a special focus on letting Johnson & Johnson vaccine recipients get a dose produced by a different company. The J&J shot produces inferior results compared to the vaccines that were created using messenger RNA technology, according to studies and real-world evidence. The main…
Johnson & Johnson Puts Talc Liabilities Into Bankruptcy
Johnson & Johnson (J&J) on Thursday put into bankruptcy tens of thousands of legal claims alleging its Baby Powder and other talc-based products caused cancer, offloading the potential liabilities into a newly created subsidiary. J&J put the talc claims into an entity called LTL Management LLC, which filed for bankruptcy protection on Thursday in North…
Second Dose of Johnson & Johnson COVID-19 Vaccine Recommended for All US Adults
Every adult 18 and older in the United States who received the single-shot Johnson & Johnson COVID-19 vaccine will be able to get a booster dose if the Food and Drug Administration (FDA) accepts a recommendation from its advisory panel. The panel unanimously voted Friday to advise the agency to authorize boosters for all adults,…
FDA Says J&J Booster Could Bolster Protection, but Not Enough Time to Independently Analyze Data
U.S. drug regulators on Wednesday said a second shot of Johnson & Johnson’s COVID-19 vaccine could bolster people’s protection against the disease, but that they did not have enough time to independently analyze the data the company submitted. Both Johnson & Johnson and Moderna are asking regulators to allow boosters for their vaccines following the…
CDC Sets Panel Meetings for J&J and Moderna Boosters, Vaccines for Children as Young as 5
The Centers for Disease Control and Prevention (CDC) will hear from its vaccine advisory panel later this month on booster shots for the Johnson & Johnson and Moderna COVID-19 vaccines and vaccinating children as young as 5. The Advisory Committee on Immunization Practices will meet on Oct. 20 and Oct. 21, followed by a second…
Johnson & Johnson Asks US Regulators to Authorize COVID-19 Booster Shot
October 5, 2021
admin
AMERICABusiness & EconomyCCP VirusCompaniesHealth NewsJohnson JohnsonMind & BodyVaccineVaccines & Safety
0 Comment
Johnson & Johnson on Tuesday asked the Food and Drug Administration (FDA) to authorize a second shot of its COVID-19 vaccine. The New Jersey-based company officially asked for an expansion of the emergency use authorization that U.S. regulators granted in late February for the single-shot vaccine. Johnson & Johnson says analysis of U.S. insurance claims…
US News
RSS Error: A feed could not be found at `https://www.theepochtimes.com/c-us/feed`; the status code is `200` and content-type is `text/html; charset=utf-8`